Gadoterate Meglumine 70436-0123-31
- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 28, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA218073
Need to source Gadoterate Meglumine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gadoterate Meglumine | 376.9 mg/mL |
Drug Class
Gadolinium-based Contrast Agent [EPC]Magnetic Resonance Contrast Activity [MoA]
Selected Package
70436-0123-31Selected10 VIAL in 1 CARTON (70436-123-31) / 5 mL in 1 VIAL
Other packages for this product(3)
10 VIAL in 1 CARTON (70436-123-33) / 10 mL in 1 VIAL
10 VIAL in 1 CARTON (70436-123-34) / 15 mL in 1 VIAL
10 VIAL in 1 CARTON (70436-123-35) / 20 mL in 1 VIAL